Automated insulin delivery for hospitalized patients with diabetes
Official title: Automated Insulin Delivery for INpatients With DysGlycemia (AIDING)
Funded at Emory University · NIH-11061804 · Data updated 2026-11-12
This study is looking at how using automated insulin delivery systems can help people with diabetes in the hospital manage their blood sugar better, especially for those who might have complicated diabetes or need extra support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | April 1, 2024 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $719,735 |
| NIH project number | 5R01DK138366-02 |
| Project ID | NIH-11061804 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include hospitalized individuals aged 21 and older who have diabetes and are experiencing dysglycemia.
✕Less likely to help
Patients who are not hospitalized or those with stable diabetes management outside of acute care settings may not benefit from this research.
What this research studies
This research investigates the use of automated insulin delivery systems to improve blood sugar control in hospitalized patients with diabetes. It aims to address the limitations of current insulin administration methods, such as multiple daily injections, which often fail to achieve optimal glycemic control. The study will explore the feasibility and effectiveness of using continuous glucose monitoring combined with automated insulin delivery in a hospital setting, particularly for patients who may be isolated or have complex diabetes types. By evaluating various factors, including the role of hospital staff and the accuracy of glucose monitoring, the research seeks to develop a scalable solution for better diabetes management in acute care.
Why it matters
Potential benefit: If successful, this research could lead to improved blood sugar management and better health outcomes for hospitalized patients with diabetes.
How similar studies have gone: Previous studies in Europe have shown positive outcomes with automated insulin delivery systems, but this research aims to address gaps in knowledge regarding their use in hospital settings.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Pasquel, Francisco J — Emory University
- Study coordinator: Pasquel, Francisco J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.